10 April 2017
The collaborative nature of the relationship between Garvan and Asan will pave the way for joint research and education projects in cancer genomics, especially in rare cancers, and related clinical trials.
The agreement will also allow for an exchange program, enabling staff and students from both Institutes to travel and collaborate on research, lectures and meetings to share their knowledge and expertise.
Garvan’s Executive Director, Professor John Mattick AO FAA says that the agreement with Asan is an example of the global cooperativity of the international research community. Driven by vastly improved communications and ease of travel, scientists are now combining their skills, knowledge and resources to gain insight into the development, progression, treatment and prevention of many diseases – not just cancer.
The Asan Medical Center is one of the largest medical centres in Asia, and is the product of the philanthropic vision of the late Chung Ju-Yung, the founder of the Hyundai Group.
According to Professor Mattick, “Working together has always been important in medical research, but never more so than today. As we enter an age of big data, and even more sophisticated research technologies, we can ask (and answer) complex questions that would have been unthinkable a few years ago.
“As the questions we ask become more ambitious, the answers are more and more likely to come from collaborative research that brings together ideas, expertise and data from around the world. We are particularly delighted to be forming collaborations with our friends in the Asia-Pacific region.”
The MOU was signed at Garvan by Professor Mattick and Professor Chang Sik Yu, President of the Asan Medical Center Cancer Institute.